PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Flexipharm Austrading Ltd
FA

Flexipharm Austrading Ltd

Bourne End
SME
flexipharmaustrading.com ↗
Compare peers
Awarded
£947.1m
Live
20
Buyers
7
12m
£932.8m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities1
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts20 / 24
  • Top buyers7
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Flexipharm Austrading LtdUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

Flexipharm Austrading Ltd has won £947.1m across 7 public-sector buyers, with 20 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 100% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
20 of 24Live contracts
100%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

⚑ Self-reported & from notices

Service tags, sectors served and target geographies appear here once a supplier verifies ownership of this profile.

Frameworks & DPS · 1 from notices
  • NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement · £944k

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 20 live · 4 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Branded Interim - 1 June 2026
NHS England—01 Jun 2026£529.1m1.9 yrspending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£403.7m2 yrspending
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024
NHS England3360000001 May 2024£11.2m4 yrsLive
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS National Generic Pharmaceuticals Wave 14a
NHS England3360000001 Feb 2023£2.1m2 yrsClosed
NHS National Pharmaceuticals Transition 2022_1
NHS England and NHS Improvement3360000029 Jul 2022£944k1.8 yrsClosed
NHS National Generic Pharmaceuticals - Wave 15c
NHS England————Live
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Procurement and Logistics Service, Business Services Organisation————Live
Generic Drugs - Injections/Infusions
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)————Live
NHS National Branded Interim - 1 June 2026
NHS England————Live
Total live value £11.2m · mean award £39.5m1–10 of 24

Top buyers · 7 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
15 contracts
100%
since 2022
2
NHS England and NHS Improvement
1 contract
0%
since 2022
3
Procurement and Logistics Service, Business Services Organisation
1 contract
0%
4
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
3 contracts
0%
5
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
2 contracts
0%
6
Procurement and Logistics Service
1 contract
0%
7
The NHS Commissioning Board (operating under the name of NHS England)
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire16 contracts
100%
Northern Ireland2 contracts
0%
Wales3 contracts
0%
Scotland2 contracts
0%
North West1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Flexipharm Austrading Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
FA
Flexipharm Austrading Ltd
Yes£932.8m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2025
Confirmation statement
Up to date
Next due 30 May 2027
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
11368401
Status
Active
Type
Private limited
Incorporated
17 May 2018
Reg. office
A T I House, 6 Boston Drive, Bourne End, Buckinghamshire, SL8 5YS
SIC codes
46180
Last accounts
31 Dec 2025
Next accounts due
30 Sept 2027

Directors & PSC

  • VLOK, Andre — director
    Appointed 02 Nov 2021
  • CLARK, Michael Leslie — director
    Appointed 17 May 2018
  • Phebra Holdings Pty Limited — person with significant control
    ownership of shares 25 to 50 percent · voting rights 25 to 50 percent
  • Mr Michael Leslie Clark — person with significant control
    ownership of shares 50 to 75 percent · voting rights 50 to 75 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
FLEXIPHARM AUSTRADING LIMITED
11368401 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.